Literature DB >> 9703952

Amino acids and peptides. XXXIII. A bifunctional poly(ethylene glycol) hybrid of laminin-related peptides.

M Maeda1, K Kawasaki, Y Mu, H Kamada, Y Tsutsumi, T J Smith, T Mayumi.   

Abstract

A novel amino acid type poly(ethylene glycol) (aaPEG) was prepared and its application as a drug-carrier was examined. The peptides, Pro-Asp-Ser-Gly-Arg (PDSGR) and Tyr-Ile-Gly-Ser-Arg (YIGSR) which are active fragments of Laminin (a cell adhesion protein), were previously reported to be inhibitors of experimental metastasis. Both peptides were conjugated with aaPEG (average molecular weight, 3,000) to prepare a bifunctional peptide-PEG hybrid. The hybrid, PDSGR-aaPEG-YIGSR, was manually prepared by the solid-phase fluorenylmethyloxycarbonyl (Fmoc) strategy. The antimetastatic activity of the peptides in mice was not lost when conjugated to form a larger aaPEG molecule. YIGSR(375 nmol) and PDSGR (375 nmol and 750 nmol) did not demonstrate antimetastatic activity, but a mixture of PDSGR (187 nnmol) and YIGSR (187 nmol) exhibited an inhibitory effect. The inhibitory effect of the hybrid (187 nmol) was more potent than that of the mixture (PDSGR and YIGSR), indicating that the inhibitory effect of the peptides was potentiated by hybrid formation with aaPEG.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9703952     DOI: 10.1006/bbrc.1998.9018

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Improving the oral efficacy of recombinant granulocyte colony-stimulating factor and transferrin fusion protein by spacer optimization.

Authors:  Yun Bai; Wei-Chiang Shen
Journal:  Pharm Res       Date:  2006-08-09       Impact factor: 4.200

2.  Enhancing Schwann cell migration using concentration gradients of laminin-derived peptides.

Authors:  Cecilia M M Motta; Kevin J Endres; Chrys Wesdemiotis; Rebecca K Willits; Matthew L Becker
Journal:  Biomaterials       Date:  2019-07-04       Impact factor: 12.479

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.